Advertisement
Screener

CRYOPORT, INC. (CYRX) Payments of Financing Costs

3.1 / 5 stars · 51/81 Roast Me

CRYOPORT, INC. Payments of Financing Costs

CRYOPORT, INC. (CYRX) reported Payments of Financing Costs of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2023-02-28.

Discontinued › Cash Flow › Financing Activities

us-gaap:PaymentsOfFinancingCosts · last filed 2023-02-28

  • CRYOPORT, INC. payments of financing costs for the quarter ending 2020-12-31 was $0.00.
  • CRYOPORT, INC. payments of financing costs for the quarter ending 2020-09-30 was $247.00K.
  • CRYOPORT, INC. payments of financing costs for the quarter ending 2020-06-30 was $3.87M.
  • CRYOPORT, INC. payments of financing costs for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
  • CRYOPORT, INC. payments of financing costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
  • CRYOPORT, INC. payments of financing costs for fiscal 2020 was $4.12M.
  • CRYOPORT, INC. payments of financing costs for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
  • CRYOPORT, INC. payments of financing costs for fiscal 2018 was $288.42K.
Period endPayments of Financing Costs 1 monthPayments of Financing Costs 3 monthPayments of Financing Costs 6 monthPayments of Financing Costs 6 month as first filedPayments of Financing Costs 9 monthPayments of Financing Costs 9 month as first filedPayments of Financing Costs 12 month
2021-12-31$0.00
10-K · filed 2023-02-28
2021-06-30$0.00
10-Q · filed 2021-08-06
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$247.00K
derived: sum of 2 quarters · filed 2023-02-28
$4.12M
derived: sum of 3 quarters · filed 2023-02-28
$4.12M
10-K · filed 2023-02-28
2020-09-30$247.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$4.12M
derived: sum of 2 quarters · filed 2021-11-04
$4.12M
10-Q · filed 2021-11-04
$4.12M
10-Q · filed 2020-11-06
$4.10M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$3.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$3.87M
10-Q · filed 2021-08-06
$3.87M
10-Q · filed 2020-08-10
$3.85M
derived: sum of 3 quarters · filed 2022-02-28
$3.85M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$0.00
10-Q · filed 2020-05-08
-$19.75K
derived: sum of 2 quarters · filed 2022-02-28
-$19.75K
derived: sum of 3 quarters · filed 2022-02-28
-$19.75K
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31-$19.75K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$19.75K
derived: sum of 2 quarters · filed 2022-02-28
-$19.75K
derived: sum of 3 quarters · filed 2022-02-28
$0.00
10-K · filed 2022-02-28
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$0.00
derived: sum of 2 quarters · filed 2020-11-06
$19.75K
10-Q · filed 2020-11-06
$308.17K
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$19.75K
10-Q · filed 2020-08-10
$308.17K
derived: sum of 3 quarters · filed 2020-08-10
$308.17K
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$19.75K
10-Q · filed 2020-05-08
$308.17K
derived: sum of 2 quarters · filed 2020-05-08
$308.17K
derived: sum of 3 quarters · filed 2020-05-08
$308.17K
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$288.42K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$288.42K
derived: sum of 2 quarters · filed 2020-03-10
$288.42K
derived: sum of 3 quarters · filed 2020-03-10
$288.42K
10-K · filed 2020-03-10
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$0.00
derived: sum of 2 quarters · filed 2019-11-12
$0.00
10-Q · filed 2019-11-12
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$0.00
10-Q · filed 2019-08-09
2018-03-31$0.00
10-Q · filed 2019-05-09
2017-12-31$0.00
10-K · filed 2019-03-13
2016-06-30$0.00
10-Q · filed 2016-08-15
2016-03-31$0.00
10-K · filed 2016-06-28
2015-06-30$89.55K
10-Q · filed 2016-08-15
$119.67K
derived: sum of 2 quarters · filed 2016-08-15
$119.67K
derived: sum of 3 quarters · filed 2016-08-15
$119.67K
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$30.12K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-28
$30.12K
derived: sum of 2 quarters · filed 2016-06-28
$30.12K
derived: sum of 3 quarters · filed 2016-06-28
$30.12K
10-K · filed 2016-06-28
2014-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05
$0.00
derived: sum of 2 quarters · filed 2015-02-05
$0.00
10-Q · filed 2015-02-05
$104.68K
derived: sum of 4 quarters · filed 2015-08-06
2014-09-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-12
$0.00
10-Q · filed 2014-11-12
$104.68K
derived: sum of 3 quarters · filed 2015-08-06
$220.56K
derived: sum of 4 quarters · filed 2015-08-06
2014-06-30$0.00
10-Q · filed 2015-08-06
$104.68K
derived: sum of 2 quarters · filed 2015-08-06
$220.56K
derived: sum of 3 quarters · filed 2015-08-06
$395.69K
derived: sum of 4 quarters · filed 2015-08-06
2014-03-31$104.68K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19
$220.56K
derived: sum of 2 quarters · filed 2015-05-19
$395.69K
derived: sum of 3 quarters · filed 2015-05-19
$463.17K
10-K · filed 2015-05-19
2013-12-31$115.88K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05
$291.01K
derived: sum of 2 quarters · filed 2015-02-05
$358.49K
10-Q · filed 2015-02-05
$436.52K
derived: sum of 4 quarters · filed 2015-02-05
2013-09-30$324.88K
10-Q · filed 2013-11-18
$175.13K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-12
$242.61K
10-Q · filed 2014-11-12
$320.64K
derived: sum of 3 quarters · filed 2014-11-12
$326.46K
derived: sum of 4 quarters · filed 2014-11-12
2013-06-30$67.47K
10-Q · filed 2014-07-31
$145.50K
derived: sum of 2 quarters · filed 2014-07-31
$151.33K
derived: sum of 3 quarters · filed 2014-07-31
$195.30K
derived: sum of 4 quarters · filed 2014-07-31
2013-03-31$78.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25
$83.85K
derived: sum of 2 quarters · filed 2014-06-25
$127.83K
derived: sum of 3 quarters · filed 2014-06-25
$206.31K
10-K · filed 2014-06-25
2012-12-31$5.82K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13
$49.80K
derived: sum of 2 quarters · filed 2014-02-13
$128.28K
10-Q · filed 2014-02-13
$128.28K
derived: sum of 4 quarters · filed 2014-02-13
2012-09-30$43.97K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18
$122.45K
10-Q · filed 2013-11-18
$122.45K
derived: sum of 3 quarters · filed 2013-11-18
$122.45K
derived: sum of 4 quarters · filed 2013-11-18
2012-06-30$78.48K
10-Q · filed 2013-08-14
$78.48K
derived: sum of 2 quarters · filed 2013-08-14
$78.48K
derived: sum of 3 quarters · filed 2013-08-14
$105.98K
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25
$0.00
derived: sum of 2 quarters · filed 2013-06-25
$27.50K
derived: sum of 3 quarters · filed 2013-06-25
$158.27K
10-K · filed 2013-06-25
2011-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14
$27.50K
derived: sum of 2 quarters · filed 2013-02-14
$158.27K
10-Q · filed 2013-02-14
$158.27K
derived: sum of 4 quarters · filed 2013-02-14
2011-09-30$27.50K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09
$158.27K
10-Q · filed 2012-11-09
$158.27K
derived: sum of 3 quarters · filed 2012-11-09
$160.17K
derived: sum of 4 quarters · filed 2012-11-09
2011-06-30$130.77K
10-Q · filed 2012-08-14
$130.77K
derived: sum of 2 quarters · filed 2012-08-14
$132.67K
derived: sum of 3 quarters · filed 2012-08-14
2011-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27
$1.90K
derived: sum of 2 quarters · filed 2012-06-27
$275.70K
10-K · filed 2012-06-27
2010-12-31$1.90K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-21
$275.70K
10-Q · filed 2012-02-21
2010-09-30$273.80K
10-Q · filed 2011-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Apnimed, Inc. (APMD)United States$0.899B
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71